Saturday, July 11, 2026

pharma · Human Immunodeficiency Virus

Beijing Cotimes Biotech

Beijing Cotimes Biotech clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Beijing, CN HQ
3 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Beijing, CN
Employees
3
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Programs

Beijing Cotimes Biotech projects

1 ClinicalTrials.gov programs sponsored by Beijing Cotimes Biotech.

Beijing Cotimes Biotech has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. TwHF

    Beijing 302 Hospital

    Human Immunodeficiency Virus

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Beijing Cotimes Biotech have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.